Table 5 Adjusted association of TANDEM size and drug-loading concentration with clinical outcomes and biochemical measures in patients with hepatocellular carcinoma.

From: The short-term safety and efficacy of TANDEM microspheres of various sizes and doxorubicin loading concentrations for hepatocellular carcinoma treatment

Outcomes

TANDEM size (ref = 100 μm)

P-value

Doxorubicin loading (ref = Full loaded)

P-value

Estimate (95% CI)

Estimate (95% CI)

Better treatment responsea

0.99 (0.30, 3.31)

0.986

4.00 (1.06, 15.13)

0.041

Length of hospital stay (days)b

− 0.84 (− 1.71, 0.02)

0.056

− 1.72 (− 2.77, -0.68)

0.001

  1. aLogistic regression was performed after adjusting for age, gender, CLIP stage, Child–Pugh Score, and total doxorubicin dosage. Odds ratio and 95% CI were presented.
  2. bLinear regression was performed after adjusting for age, gender, CLIP stage, Child–Pugh Score, and total doxorubicin dosage. The regression coefficients (β) indicated the difference in days between TANDEM size or doxorubicin-loading groups.
Back to article page